BioNTech SE (BNTX) Other Non Operating Income (2023 - 2025)
BioNTech SE (BNTX) posted Other Non Operating Income of -$71.7 million for Q2 2025, down 120.45% on a QoQ basis from -$32.5 million in Q1 2025, and down 901.65% year-over-year from $8.9 million in Q2 2024.
BioNTech SE (BNTX) has 3 years of Other Non Operating Income data on file, last reported at -$71.7 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | BioNTech SE | 27.66 Bn | 7.53 Bn | 668.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -71.65 Mn |
| Mar 31, 2025 | -32.50 Mn |
| Sep 30, 2024 | -13.18 Mn |
| Jun 30, 2024 | 8.94 Mn |
| Mar 31, 2024 | 16.73 Mn |
| Sep 30, 2023 | 4.25 Mn |
| Jun 30, 2023 | -2.40 Mn |
| Mar 31, 2023 | -2.25 Mn |